(2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride

C130H173AgBr6ClF10N21O23P — CID 165028032

IUPAC(2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride
SMILESBrC(Br)(Br)Br.C1COCCN1.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CBr.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CN1CCOCC1.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CO.C[C@@H](Br)C(=O)Nc1ccc(OCC2CC2)nn1.C[C@@H](C(=O)Nc1ccc(OCC2CC2)nn1)N1CCC(F)(F)[C@@H](c2c[nH]c(=O)c(CN3CCOCC3)c2)C1.Cl.O=[N+]([O-])O.O=c1[nH]cc(C2CNCCC2(F)F)cc1CN1CCOCC1.[Ag].c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C26H34F2N6O4.C21H31F2N3O4.C18H15P.C17H23BrF2N2O3.C17H24F2N2O4.C15H21F2N3O2.C11H14BrN3O2.C4H9NO.CBr4.Ag.ClH.HNO3/c1-17(24(35)30-22-4-5-23(32-31-22)38-16-18-2-3-18)34-7-6-26(27,28)21(15-34)19-12-20(25(36)29-13-19)14-33-8-10-37-11-9-33;1-20(2,3)30-19(27)26-6-5-21(22,23)17(14-26)15-11-16(18(28-4)24-12-15)13-25-7-9-29-10-8-25;1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2,3)25-15(23)22-6-5-17(19,20)13(10-22)12-7-11(8-18)14(24-4)21-9-12;1-16(2,3)25-15(23)21-6-5-17(18,19)13(9-21)11-7-12(10-22)14(24-4)20-8-11;16-15(17)1-2-18-9-13(15)11-7-12(14(21)19-8-11)10-20-3-5-22-6-4-20;1-7(12)11(16)13-9-4-5-10(15-14-9)17-6-8-2-3-8;1-3-6-4-2-5-1;2-1(3,4)5;;;2-1(3)4/h4-5,12-13,17-18,21H,2-3,6-11,14-16H2,1H3,(H,29,36)(H,30,31,35);11-12,17H,5-10,13-14H2,1-4H3;1-15H;7,9,13H,5-6,8,10H2,1-4H3;7-8,13,22H,5-6,9-10H2,1-4H3;7-8,13,18H,1-6,9-10H2,(H,19,21);4-5,7-8H,2-3,6H2,1H3,(H,13,14,16);5H,1-4H2;;;1H;(H,2,3,4)/t17-,21+;;;;;;7-;;;;;/m0.....1...../s1
InChIKeyGGIVUCOGCGGVDU-JGUIWWDMSA-N
MW3241.64 g/mol
LogP22.01
Rot. Bonds30

About (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride

(2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride (PubChem CID 165028032) has the molecular formula C130H173AgBr6ClF10N21O23P and a molecular weight of 3241.64 g/mol. Its IUPAC name is (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride.

Molecular Properties

Compound Name(2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride
PubChem CID165028032
Molecular FormulaC130H173AgBr6ClF10N21O23P
Molecular Weight3241.64 g/mol
Exact Mass3232.64
IUPAC Name(2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride
SMILESBrC(Br)(Br)Br.C1COCCN1.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CBr.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CN1CCOCC1.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CO.C[C@@H](Br)C(=O)Nc1ccc(OCC2CC2)nn1.C[C@@H](C(=O)Nc1ccc(OCC2CC2)nn1)N1CCC(F)(F)[C@@H](c2c[nH]c(=O)c(CN3CCOCC3)c2)C1.Cl.O=[N+]([O-])O.O=c1[nH]cc(C2CNCCC2(F)F)cc1CN1CCOCC1.[Ag].c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C26H34F2N6O4.C21H31F2N3O4.C18H15P.C17H23BrF2N2O3.C17H24F2N2O4.C15H21F2N3O2.C11H14BrN3O2.C4H9NO.CBr4.Ag.ClH.HNO3/c1-17(24(35)30-22-4-5-23(32-31-22)38-16-18-2-3-18)34-7-6-26(27,28)21(15-34)19-12-20(25(36)29-13-19)14-33-8-10-37-11-9-33;1-20(2,3)30-19(27)26-6-5-21(22,23)17(14-26)15-11-16(18(28-4)24-12-15)13-25-7-9-29-10-8-25;1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2,3)25-15(23)22-6-5-17(19,20)13(10-22)12-7-11(8-18)14(24-4)21-9-12;1-16(2,3)25-15(23)21-6-5-17(18,19)13(9-21)11-7-12(10-22)14(24-4)20-8-11;16-15(17)1-2-18-9-13(15)11-7-12(14(21)19-8-11)10-20-3-5-22-6-4-20;1-7(12)11(16)13-9-4-5-10(15-14-9)17-6-8-2-3-8;1-3-6-4-2-5-1;2-1(3,4)5;;;2-1(3)4/h4-5,12-13,17-18,21H,2-3,6-11,14-16H2,1H3,(H,29,36)(H,30,31,35);11-12,17H,5-10,13-14H2,1-4H3;1-15H;7,9,13H,5-6,8,10H2,1-4H3;7-8,13,22H,5-6,9-10H2,1-4H3;7-8,13,18H,1-6,9-10H2,(H,19,21);4-5,7-8H,2-3,6H2,1H3,(H,13,14,16);5H,1-4H2;;;1H;(H,2,3,4)/t17-,21+;;;;;;7-;;;;;/m0.....1...../s1
InChIKeyGGIVUCOGCGGVDU-JGUIWWDMSA-N
XLogP22.01
TPSA506.46 Ų
H-Bond Donors8
H-Bond Acceptors35
Rotatable Bonds30
Heavy Atoms193
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003241.64
LogP ≤ 522.01
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride?
The IUPAC name of (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride (CID 165028032) is (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride.
What is the SMILES notation for (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride?
The canonical SMILES for (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride is BrC(Br)(Br)Br.C1COCCN1.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CBr.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CN1CCOCC1.COc1ncc(C2CN(C(=O)OC(C)(C)C)CCC2(F)F)cc1CO.C[C@@H](Br)C(=O)Nc1ccc(OCC2CC2)nn1.C[C@@H](C(=O)Nc1ccc(OCC2CC2)nn1)N1CCC(F)(F)[C@@H](c2c[nH]c(=O)c(CN3CCOCC3)c2)C1.Cl.O=[N+]([O-])O.O=c1[nH]cc(C2CNCCC2(F)F)cc1CN1CCOCC1.[Ag].c1ccc(P(c2ccccc2)c2ccccc2)cc1.
What is the InChIKey of (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride?
The InChIKey is GGIVUCOGCGGVDU-JGUIWWDMSA-N. The full InChI is InChI=1S/C26H34F2N6O4.C21H31F2N3O4.C18H15P.C17H23BrF2N2O3.C17H24F2N2O4.C15H21F2N3O2.C11H14BrN3O2.C4H9NO.CBr4.Ag.ClH.HNO3/c1-17(24(35)30-22-4-5-23(32-31-22)38-16-18-2-3-18)34-7-6-26(27,28)21(15-34)19-12-20(25(36)29-13-19)14-33-8-10-37-11-9-33;1-20(2,3)30-19(27)26-6-5-21(22,23)17(14-26)15-11-16(18(28-4)24-12-15)13-25-7-9-29-10-8-25;1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-16(2,3)25-15(23)22-6-5-17(19,20)13(10-22)12-7-11(8-18)14(24-4)21-9-12;1-16(2,3)25-15(23)21-6-5-17(18,19)13(9-21)11-7-12(10-22)14(24-4)20-8-11;16-15(17)1-2-18-9-13(15)11-7-12(14(21)19-8-11)10-20-3-5-22-6-4-20;1-7(12)11(16)13-9-4-5-10(15-14-9)17-6-8-2-3-8;1-3-6-4-2-5-1;2-1(3,4)5;;;2-1(3)4/h4-5,12-13,17-18,21H,2-3,6-11,14-16H2,1H3,(H,29,36)(H,30,31,35);11-12,17H,5-10,13-14H2,1-4H3;1-15H;7,9,13H,5-6,8,10H2,1-4H3;7-8,13,22H,5-6,9-10H2,1-4H3;7-8,13,18H,1-6,9-10H2,(H,19,21);4-5,7-8H,2-3,6H2,1H3,(H,13,14,16);5H,1-4H2;;;1H;(H,2,3,4)/t17-,21+;;;;;;7-;;;;;/m0.....1...../s1.
What are the key properties of (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride?
(2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride has a molecular weight of 3241.64 g/mol, XLogP of 22.01, 30 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-bromo-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]propanamide;tert-butyl 3-[5-(bromomethyl)-6-methoxy-3-pyridinyl]-4,4-difluoropiperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[5-(hydroxymethyl)-6-methoxy-3-pyridinyl]piperidine-1-carboxylate;tert-butyl 4,4-difluoro-3-[6-methoxy-5-(morpholin-4-ylmethyl)-3-pyridinyl]piperidine-1-carboxylate;(2S)-N-[6-(cyclopropylmethoxy)pyridazin-3-yl]-2-[(3S)-4,4-difluoro-3-[5-(morpholin-4-ylmethyl)-6-oxo-1H-pyridin-3-yl]piperidin-1-yl]propanamide;5-(4,4-difluoropiperidin-3-yl)-3-(morpholin-4-ylmethyl)-1H-pyridin-2-one;morpholine;nitric acid;silver;tetrabromomethane;triphenylphosphane;hydrochloride is sourced from PubChem (CID 165028032), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).